NB-001 (NysnoBio)

N/A

Report date: 2025/02/21 14:35:09

Base Information

Drug NameNB-001 (NysnoBio)
Drug Alias NameNB001NB-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionE3 ubiquitin-protein ligase parkin gene transference
TargetsE3 ubiquitin-protein ligase parkin
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNysnoBio LLC
China Registration ClassN/A

Develop Information

Active CompaniesNysnoBio LLC
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A